Astria Therapeutics (ATXS.US) Latest Stock News - Major News Analysis

Event Tracking

Dec3

BioCryst Pharmaceuticals Plans to Merge with Astria Therapeutics

12:00

Nov13

Astria Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 706 K (forecast USD 10.67 M), actual EPS USD -0.5455 (forecast USD -0.39)

04:00

Astria Therapeutics released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 706 K, actual EPS USD -1.6964

04:00

Nov12

BioCryst Pharmaceuticals to Acquire Astria Therapeutics for $8.55 per Share and 0.59 Shares

13:03

Oct14

BioCryst Pharmaceuticals Acquires Astria Therapeutics for Cash and Stock

11:01

Oct8

Astria Therapeutics Launches Third-Stage Long-Term Trial of Navenibart for HAE

12:01

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 706 K, Net Income -31.64 M, EPS -0.5455

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -33.05 M, EPS -0.5698

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -33.71 M, EPS -0.5811

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change